Skip to content
What's New in Pharmacy Read our Latest Insights

FAQs About NCPDP F6 Readiness

Posted on November 17, 2026

Read Time: 0 min

F6 Basics and Timeline

What is the NCPDP F6 standard?

F6 is replacing D.0 as the federally required NCPDP Telecommunication Standard for retail pharmacy claims. It’s the first full rebuild of the pharmacy claim standard in more than a decade, so both the claim data and the systems that read it are changing. F6 fills gaps that D.0 handled with manual splits, free-text workarounds, and field workarounds. It also supports specialty adjudication, 8-byte IIN routing, ePA, and real-time benefit checks.

When is the F6 compliance deadline?

Dual use opens on August 14, 2027. From then on, pharmacy stakeholders can exchange claims in either D.0 or F6 by agreement. Full compliance is required by April 14, 2028, when D.0 is retired. Most of the readiness work should be finished before dual use begins, so August 2027 is the date to plan around.

Why is the pharmacy claim standard changing now?

Because HHS has now made it a requirement. D.0 has been stretched past its original design to handle million-dollar drugs, modern routing, and other needs it wasn’t built for. F6 brings the standard up to date. That opens the door to better data exchange, clearer data flows, and more efficient operations across the pharmacy ecosystem.

Who Owns Transition Actions

Isn’t our PBM handling the F6 transition for us?

Your PBM is preparing its own platform, but PBM readiness is not the same as health plan readiness. The PBM’s job is to get the claim adjudicated; the plan still owns what happens to that data afterward, including reporting, reconciliation, finance, and audit. Downstream vendors may also rely on the plan for education and coordination. Planning your side of the handoff now helps protect members from disruption at the pharmacy counter and prevents downstream issues that can surface even after claims are processed at the point of sale.

What parts of the F6 transition does a health plan own?

Many decisions sit outside the claims engine, including testing strategy, partner sequencing, downstream file validation, reconciliation, member communication, and escalation ownership. Eligibility is owned by the health plan and is the first link in the chain, since every later claim and member-service step depends on it. The plan also keeps its own regulatory compliance responsibility.

Who is affected by the D.0 to F6 transition?

Any organization that sends, adjudicates, routes, uses, explains, or relies on pharmacy claim data is affected. That includes health plans, PBMs, employers, pharmacies, switches, and the downstream vendors that ingest claim, eligibility, or financial files.

Dual Use Period and Operational Impact

What is the F6 dual-use period?

Dual use is the window when organizations may need to support D.0 and F6 claims at the same time, depending on how ready each pharmacy stakeholder is. It’s more than a testing exercise. It calls for decisions about which partners and lines of business move first, plus monitoring of reject rates, accumulator variances, and help desk drivers. Organizations need to be operationally ready before dual use begins rather than using that period to start testing.

Can a claim pay correctly and still cause problems under F6?

Yes. F6 changes coordination of benefits, patient-pay, and claim-matching data that feed accumulators, TrOOP, reporting, and reconciliation. A claim can pay at the counter while a balance or report goes wrong downstream. For members, that can mean the wrong out-of-pocket amount with no error to flag it. For Medicare lines, it can turn into audit exposure discovered months later. For pharmacy leaders, that means a successful claim alone is not enough to confirm that members, reporting, and downstream operations are protected.

Is F6 just an IT project?

No. F6 affects manual processes and field-level procedures, not only technology. Documentation, SOPs, and training materials all need updates. Testing must confirm business outcomes and the pharmacy experience, not just that the new fields are present. F6 works best as a readiness program owned by leadership rather than something handed to IT alone.

Planning, Budget, and Resources

How many teams does F6 affect?

Usually more than organizations expect. With roughly 200 new fields, 150 modified fields, and 50 removed fields, the changes reach well beyond the claims engine. Claims, finance, reporting, compliance, customer service, analytics, and vendor management all have a role. Success depends on cross-functional ownership and governance. Many of these teams are also working on other industry standards and projects at the same time.

When should we budget for F6?

Now, if you haven’t already. F6 work typically spans more than one budget cycle, with build, partner testing, and dual-use support continuing through the April 14, 2028 compliance date, so funding will likely be needed in 2027 and beyond. Organizations that plan early keep more options for staffing, sequencing, and vendor coordination. Waiting can leave too little runway before dual use.

Working with PSG

How can PSG help with F6 readiness?

PSG helps organizations own their side of the F6 transition, including the plan-owned decisions outlined above: testing strategy, partner sequencing, downstream validation, and reconciliation. Our support is tiered to meet organizations where they are. As both pharmacy and business transformation experts, we bring decades of experience with complex pharmacy benefit transitions. If you have questions about where your organization sits on the F6 readiness spectrum or need more hands-on support with the transition, contact us to start the conversation.